Congressional Republicans Call For Reconsideration Of Administration Anti-Innovation Drug-Price Policy
April 13, 2023
April 13, 2023
WASHINGTON, April 13 -- Sen. Mike Crapo, R-Idaho, ranking member of the Senate Finance Committee, issued the following news release:
U.S. Senator Mike Crapo (R-Idaho), Ranking Member of the Senate Finance Committee, U.S. House Ways and Means Chair Jason Smith (R-Missouri) and U.S. House Energy and Commerce Chair Cathy McMorris Rodgers (R-Washington) raised concerns with the Biden Administration's initial drug price-setting program implementation guidance document.
In a . . .
U.S. Senator Mike Crapo (R-Idaho), Ranking Member of the Senate Finance Committee, U.S. House Ways and Means Chair Jason Smith (R-Missouri) and U.S. House Energy and Commerce Chair Cathy McMorris Rodgers (R-Washington) raised concerns with the Biden Administration's initial drug price-setting program implementation guidance document.
In a . . .